Dean Y. Li - 02 Jan 2026 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
02 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Jan 2026, 17:47:45 UTC
Previous filing
03 Oct 2025
Next filing
28 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Li Dean Y Director C/O RECURSION PHARMACEUTICALS, 41 S. RIO GRANDE STREET, SALT LAKE CITY /s/ Jonathan Golightly, attorney-in-fact 06 Jan 2026 0001837016

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +2,381 +0.19% $0.000000 1,240,909 02 Jan 2026 Direct F1
holding RXRX Class A Common Stock 1,422,048 02 Jan 2026 By Dean Y. Li Revocable Trust
holding RXRX Class A Common Stock 136,981 02 Jan 2026 By Dean Y. Li GRAT
holding RXRX Class A Common Stock 421,000 02 Jan 2026 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.